- The trend backdrop is active with a 20-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is constructive, supporting the smart-money activity read.
- Latest weekly return ranks in the strongest part of its sector group.
XVIVO
STO
Week ended 07 Aug 2026
Weekly Investor Report
Xvivo Perfusion AB (publ) · Healthcare · Medical Devices
Latest close
278.6 SEK
5.6%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 13.9% above the Trend Line and sits at 78.9% of its 52-week range. The latest completed week returned 5.6%, after a -0.9% four-week move. The latest news-sentiment score is 50/100.
Setup score
58
out of 100
Latest Close
278.6 SEK
7 Aug 2026
1W Return
5.6%
latest completed week
4W Return
-0.9%
short-term follow-through
12W Return
-3.5%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
5.6%
Latest completed week; four-week move -0.9%.
Indicator stack
72/34
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
14 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 13.9% above the Trend Line and sits at 78.9% of its 52-week range. The latest completed week returned 5.6%, after a -0.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5612-week average 0.80
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.56Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.9% over four weeks, -3.5% over 12 weeks, and 47.6% over one year. The current trend has remained active for 20 consecutive weeks.
Performance by holding period
Active trend streak20 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.59Latest activity-pressure read.
Pressure change-61.4%Four-week change in activity pressure.
Leadership15.50Latest relative-leadership reading.
RS change-27.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 14 relevant articles.
3 positive · 11 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.2%Distance below the 52-week high.
13-week volatility6.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+21.7%Week of 27 Mar.
Worst week-15.1%Week of 17 Jul.
Latest week+5.6%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains7
Flat weeks0
Modest losses6
Sharp losses5
Recent vol6.7%13-week weekly-return volatility.
Base vol7.1%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew5.7% / -4.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank53 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Medical Devices
4-week rank20 / 46
Group average-3.1%
Trend breadth23.9%
Trend23.9%active weekly trend signals
MD41.3%positive activity pressure
RS10.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape61/100
Trend, activity pressure, participation, and risk combine to a 61/100 tape read.
Indicator analysis73/100Latest 12-week confirmation: trend 12/12, activity pressure 6/12, relative leadership 12/12.
Activity pressure 0.56; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 14 relevant articles.
Winton Capital Management no longer a public short seller in Xvivo Perfusion Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 278.6 SEK | 5.6% | 244.5 SEK | 314.5 SEK | -0.59 | 15.50 | 256.4K | On |
| 31 Jul 2026 | 263.8 SEK | 12.2% | 241.7 SEK | 314.6 SEK | -0.65 | 11.91 | 271.1K | On |
| 24 Jul 2026 | 235.2 SEK | -1.4% | 239.0 SEK | 314.9 SEK | -0.63 | 1.34 | 217.5K | On |
| 17 Jul 2026 | 238.6 SEK | -15.1% | 237.3 SEK | 315.4 SEK | -0.47 | 4.18 | 684.6K | On |
| 10 Jul 2026 | 281.2 SEK | 0.4% | 235.6 SEK | 315.8 SEK | -0.37 | 21.35 | 169.5K | On |
| 3 Jul 2026 | 280.0 SEK | 8.3% | 232.2 SEK | 315.9 SEK | -0.12 | 18.55 | 106.8K | On |
| 26 Jun 2026 | 258.6 SEK | 2.3% | 229.0 SEK | 316.1 SEK | 0.16 | 11.84 | 28.9K | On |
| 19 Jun 2026 | 252.8 SEK | -7.4% | 226.6 SEK | 316.4 SEK | 0.51 | 7.52 | 246.8K | On |
| 12 Jun 2026 | 273.0 SEK | -1.7% | 223.6 SEK | 316.8 SEK | 0.86 | 17.48 | 44.0K | On |
| 5 Jun 2026 | 277.6 SEK | 0.3% | 220.0 SEK | 316.8 SEK | 1.07 | 18.32 | 36.3K | On |
| 29 May 2026 | 276.8 SEK | -6.0% | 216.4 SEK | 316.8 SEK | 1.20 | 16.07 | 370.0K | On |
| 22 May 2026 | 294.4 SEK | 2.0% | 213.5 SEK | 316.9 SEK | 1.24 | 22.07 | 236.3K | On |
| 15 May 2026 | 288.6 SEK | 0.9% | 210.3 SEK | 316.8 SEK | 1.30 | 23.11 | 179.3K | On |
| 8 May 2026 | 286.0 SEK | 4.2% | 206.3 SEK | 316.9 SEK | 1.41 | 19.60 | 398.6K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.